Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Carbon Ion Radiotheray

Tundra lists 3 Carbon Ion Radiotheray clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07035860

Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer

This is the first prospective clinical study to evaluate the efficacy and safety of induction chemoimmunotherapy followed by carbon ion radiotherapy and consolidation immunotherapy in patients with unresectable locally advanced non-small cell lung cancer (NSCLC). Based on this prospective study, tumor tissue, blood, urine, and stool samples from participants will be collected and analyzed to identify predictive markers of treatment response.

Gender: All

Ages: 18 Years - 75 Years

Updated: 2025-06-25

1 state

Carbon Ion Radiotheray
RECRUITING

NCT06311955

Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor

To observe the efficacy and toxicities of heavy ion radiation therapy for locally advanced or advanced primary thymic epithelial malignant tumor received R2 resection. The primary endpoint was progression-free survival and toxicities, and the secondary endpoint was local relapse-free survival, overall survival and cause-specific survival.

Gender: All

Ages: 18 Years - 70 Years

Updated: 2025-06-13

1 state

Thymic Epithelial Tumor
Radiotherapy Side Effect
Carbon Ion Radiotheray
+1
RECRUITING

NCT06831773

Clinical Study of Carbon Ion Radiotherapy for High-grade Glioma

The objective is to use the advantages of heavy ion physical dosimetry and biology to improve the tumor control rate and long-term survival rate of high-grade glioma, reduce the occurrence of brain tissue radiation damage caused by increasing prescription dose, and provide new treatment suggestions for glioma radiotherapy.

Gender: All

Ages: 14 Years - 80 Years

Updated: 2025-02-18

1 state

Carbon Ion Radiotheray
High-grade Glioma
Heavy Ion Radiotherapy